Six Minute Walk Test: A Tool for Predicting Mortality in Chronic Pulmonary Diseases

Overview

Journal J Clin Diagn Res

Specialty General Medicine

Date 2017 Jun 3

PMID 28571188

Citations 17

Authors

Mp Swathi Karanth

Nilkanth Tukaram Awad

Affiliations

Soon will be listed here.

Abstract

Introduction: Six Minute Walk Test (6MWT) is a simple test used to measure exercise capacity in Chronic Pulmonary Diseases (CPDs). Decreased exercise capacity significantly affects the quality of life. The 6MWT is a known tool to measure exercise capacity and quality of life in CPD. However, the role of change in follow up Six Minute Walk Distance (6MWD) in assessing mortality and its correlation with known prognostic factors haven't been tested to the best of our knowledge.

Aim: To study the correlation of change in 6MWD with change in spirometry and to study the role of 6MWD in predicting mortality in CPD.

Settings And Design: Prospective cohort study.

Materials And Methods: A total of 139 CPD patients were grouped into obstructive, restrictive and post Tuberculosis (TB) sequelae. Optimized treatment was given and they were followed up regularly. Spirometry and 6MWT was done at the beginning and after one year. Mean decline in FEV1, FVC was correlated with mean decline in 6MWD.

Statistical Analysis: With STATA 13.1 correlation between 6MWT and spirometric values were done using Wilcoxon signed rank test. Predictors of mortality were studied using multivariate analysis.

Results: Overall mean decline in 6MWD was 16.07 m/year. There was no correlation between mean change in 6MWD and change in FEV1, FVC, and FEV1/FVC. On multivariate analysis, 6MWD was the better predictor of mortality than FEV1 (p<0.001), FVC (p<0.001). At cut off value of 240 meters, sensitivity and specificity of 6MWT in predicting mortality was 71.05% and 81.94% respectively.

Conclusion: The 6MWD changes independently and has no correlation with change in spirometry, it is an independent predictor of mortality in CPD.

Citing Articles

Whole body resistance training on functional outcomes of patients with Stage 4 or 5 chronic kidney disease: A systematic review.

Abrahim S, Steele A, Voth J, Krepinsky J, Lanktree M, Hawke T Physiol Rep. 2024; 12(15):e16151.

PMID: 39134506 PMC: 11319065. DOI: 10.14814/phy2.16151.

Association between Physical Function, Mental Function and Frailty in Community-Dwelling Older Adults: A Cross-Sectional Study.

Park H, Thapa N, Bae S, Yang J, Choi J, Noh E J Clin Med. 2024; 13(11).

PMID: 38892918 PMC: 11172678. DOI: 10.3390/jcm13113207.

Effects of combined aerobic, resistance and inspiratory training in patients with pulmonary hypertension: A systematic review.

Kourek C, Zachariou A, Karatzanos E, Antonopoulos M, Soulele T, Karabinis A World J Crit Care Med. 2024; 13(2):92585.

PMID: 38855278 PMC: 11155510. DOI: 10.5492/wjccm.v13.i2.92585.

The Impact of Positive Expiratory Pressure Therapy on Hyperinflation in Patients With COPD.

de Macedo J, Conceicaodos Dos Santos E, Reychler G, Poncin W Respir Care. 2024; 69(3):366-375.

PMID: 38416659 PMC: 10984590. DOI: 10.4187/respcare.11039.

Study the association between spirometry based functional grading and six minute walk distance in chronic respiratory disease patients at a rural tertiary care centre of India.

Yadav P, Mishra A, Kumar A, Gupta A, Gautam A, Singh N Ann Afr Med. 2024; 22(4):526-531.

PMID: 38358156 PMC: 10775948. DOI: 10.4103/aam.aam_19_23.

References

Watz H, Waschki B, Meyer T, Magnussen H . Physical activity in patients with COPD. Eur Respir J. 2008; 33(2):262-72. DOI: 10.1183/09031936.00024608. View

Gosker H, Engelen M, van Mameren H, van Dijk P, van der Vusse G, Wouters E . Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr. 2002; 76(1):113-9. DOI: 10.1093/ajcn/76.1.113. View

Vargha G . Fifteen year follow-up of lung function in obstructive and non-obstructive pulmonary tuberculosis. Acta Med Hung. 1983; 40(4):271-6. View

Pinto-Plata V, Cote C, Cabral H, Taylor J, Celli B . The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004; 23(1):28-33. DOI: 10.1183/09031936.03.00034603. View

. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-7. DOI: 10.1164/ajrccm.166.1.at1102. View

Enright P, Sherrill D . Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998; 158(5 Pt 1):1384-7. DOI: 10.1164/ajrccm.158.5.9710086. View

Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H . Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2007; 177(7):743-51. DOI: 10.1164/rccm.200707-1011OC. View

Anthonisen N, Wright E, Hodgkin J . Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986; 133(1):14-20. DOI: 10.1164/arrd.1986.133.1.14. View

Fabbri L, Rabe K . From COPD to chronic systemic inflammatory syndrome?. Lancet. 2007; 370(9589):797-9. DOI: 10.1016/S0140-6736(07)61383-X. View

10.

WALKER P, Burnett A, Flavahan P, Calverley P . Lower limb activity and its determinants in COPD. Thorax. 2008; 63(8):683-9. DOI: 10.1136/thx.2007.087130. View

11.

Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M . Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2000; 161(2 Pt 1):487-92. DOI: 10.1164/ajrccm.161.2.9906015. View

12.

Casanova C, de Torres J, Aguirre-Jaime A, Pinto-Plata V, Marin J, Cordoba E . The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011; 184(9):1015-21. DOI: 10.1164/rccm.201105-0831OC. View

13.

Sivaranjini S, Vanamail P, Eason J . Six minute walk test in people with tuberculosis sequelae. Cardiopulm Phys Ther J. 2010; 21(3):5-10. PMC: 2941351. View

14.

du Bois R, Weycker D, Albera C, Bradford W, Costabel U, Kartashov A . Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med. 2010; 183(9):1231-7. DOI: 10.1164/rccm.201007-1179OC. View

15.

Fernandez Perez E, Daniels C, Schroeder D, St Sauver J, Hartman T, Bartholmai B . Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study. Chest. 2009; 137(1):129-37. PMC: 2803118. DOI: 10.1378/chest.09-1002. View

16.

Flaherty K, Andrei A, Murray S, Fraley C, Colby T, Travis W . Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med. 2006; 174(7):803-9. PMC: 2648064. DOI: 10.1164/rccm.200604-488OC. View

17.

Qiu T, Tang Y, Xu Z, Xu D, Xiao J, Zhang M . Association between body mass index and pulmonary function of patients with chronic obstructive pulmonary disease. Chin Med J (Engl). 2009; 122(9):1110-1. View

18.

Ramanathan R, Chandrasekaran B . Reference equations for 6-min walk test in healthy Indian subjects (25-80 years). Lung India. 2014; 31(1):35-8. PMC: 3960806. DOI: 10.4103/0970-2113.125892. View

19.

Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E . Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009; 180(6):506-12. DOI: 10.1164/rccm.200812-1873OC. View

20.

Similowski T, Agusti A, MacNee W, Schonhofer B . The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006; 27(2):390-6. DOI: 10.1183/09031936.06.00143704. View